Replies to post #24474 on RespireRx Pharmaceuticals Inc (RSPI)

[food4thought]

Market,
If you believe that, then you have to believe that crease and iggs have infiltrated the scam and are desperately trying, in a rather unintelligible manner, to protect us and ward off future investors. Could be? I don't know, but I doubt that the CEO of Cor would choose to pr layoffs if his primary goal was to lure cash from more would be sucker investors. The layoffs represent to me a desperation move, but by doing so also creates for me a sense of anticipation. It looks like they may have found a near term reason to aggressively extend the life of their remaining cash without dilution. Logically, again to me, it's the hope of good SA data. Rd poc apparently was not an appealing enough, or would be lucrative enough, indication on its own for potential partners to further study. Either too difficult to trial or too timely, who knows? This last ditch effort is the logical choice to avoid needless and further dilution. It will afford Cor the time they need if they indeed have a cash cow on the horizon, again without further dilution. In my opinion, this is one of the first things management has done in recent past to assure me that they may truly have my interests as a shareholder in mind. They could have just as easily given away the farm through some sort of ridiculously configured pipe that would have once again padded management's pockets with endless options. They remain under water like the rest of us. Am I happy where we currently sit, no, but this to me signals aggressive action which hopefully will result in higher shareholder value.

If I'm wrong, we pack the louisville slugger and head to soco. Anyone for a kneecap homer? My motto is clear, it's easier to forgive when the source of your pain is crying louder than you are. :o) Bottoms up!

[bigworld]

MF: Wise thinking regarding small-fry biotechs. They are a losers game as I have so painfully found out. I'm holding COR until the bitter end. What point is there in selling now? Consider it an option without an expiration, except perhaps bankruptcy. I'll never invest in another small biotech ever again. There is too much money to be made in safer areas of the market. I've done really well with oil (PBR) and gold miners (GDX). I've also almost doubled my money in a week with Hecla Mining (HL). I have 4 remaining small biotechs...COR, PPHM, CVM and AVII. I only need one of them to be successful to break even, but that is perhaps doubtful. Big Pharma seems to be content to merge with other big Pharma, depleting available aquisition capital. These small companies are cash starved and running on fumes. It's hard to make progress scientifically when the money starts to run out. It's too bad. Lots of promising science will probably die on the vine by year end, victims of the current financing environment.